Food Safety Modernization Act Third-Party Certification Program User Fee Rate for Fiscal Year 2020, 35395-35398 [2019-15622]

Download as PDF Federal Register / Vol. 84, No. 141 / Tuesday, July 23, 2019 / Notices 35395 TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued Activity; 21 CFR section FDA form No.2 Number of respondents Number of responses per respondent Total annual responses Average burden per response Total hours Biennial renewals; 1.235 ..... 3rd party registration verification. U.S. Agent verification ........ 3537 3537 97,883 41,256 1 1 97,883 41,256 0.38 (23 minutes) ............... 0.25 (15 minutes) ............... 37,196 10,314 3537 57,070 1 57,070 0.25 (15 minutes) ............... 14,268 Total ............................. ........................ ........................ ........................ ........................ ............................................. 278,382 1 There are no capital costs or operating and maintenance costs associated with this collection of information. 2 Forms FDA 3537 and FDA 3537a refer to both the paper version of the form and the electronic system known as the Food Facility Registration Module, which is available at https://www.access.fda.gov. These burden figures are based on currently available data and reflect an overall decrease to the information collection by 174,395 and 31,370 hours. The decrease results from the realization of burden associated with implementing measures on newly established electronic registration requirements. Dated: July 17, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019–15636 Filed 7–22–19; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2016–N–4119] Food Safety Modernization Act ThirdParty Certification Program User Fee Rate for Fiscal Year 2020 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing the fiscal year (FY) 2020 annual fee rate for recognized accreditation bodies and accredited certification bodies, and the fee rate for accreditation bodies applying to be recognized in the thirdparty certification program that is authorized by the Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the FDA Food Safety Modernization Act (FSMA). We are also announcing the fee rate for certification bodies that are applying to be directly accredited by FDA. DATES: This fee is effective October 1, 2019. jspears on DSK30JT082PROD with NOTICES SUMMARY: FOR FURTHER INFORMATION CONTACT: Donald Prater, Office of Food Policy and Response, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, Rm. 3202, Silver Spring, MD 20993, 301–348–3007. VerDate Sep<11>2014 16:43 Jul 22, 2019 Jkt 247001 SUPPLEMENTARY INFORMATION: I. Background Section 307 of FSMA (Pub. L. 111– 153), Accreditation of Third-Party Auditors, amended the FD&C Act to create a new provision, section 808, under the same name. Section 808 of the FD&C Act (21 U.S.C. 384d) directs FDA to establish a program for accreditation of third-party certification bodies 1 conducting food safety audits and issuing food and facility certifications to eligible foreign entities (including registered foreign food facilities) that meet our applicable requirements. Under this provision, we established a system for FDA to recognize accreditation bodies to accredit certification bodies, except for limited circumstances in which we may directly accredit certification bodies to participate in the third-party certification program. Section 808(c)(8) of the FD&C Act directs FDA to establish a reimbursement (user fee) program by which we assess fees and require reimbursement for the work FDA performs to establish and administer the third-party certification program under section 808 of the FD&C Act. The user fee program for the third-party certification program was established by a final rule entitled ‘‘Amendments to Accreditation of Third-Party Certification Bodies To Conduct Food Safety Audits and To Issue Certifications To Provide for the User Fee Program’’ (81 FR 90186, December 14, 2016). The FSMA FY 2020 third-party certification program user fee rate announced in this notice is effective on October 1, 2019, and will remain in effect through September 30, 2020. 1 For the reasons explained in the third-party certification final rule (80 FR 74570 at 74578 to 74579, November 27, 2015), and for consistency with the implementing regulations for the thirdparty certification program in 21 CFR parts 1, 11, and 16, this notice uses the term ‘‘third-party certification body’’ rather than the term ‘‘third-party auditor’’ used in section 808(a)(3) of the FD&C Act. PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 II. Estimating the Average Cost of a Supported Direct FDA Work Hour for FY 2020 FDA must estimate its costs for each activity in order to establish fee rates for FY 2020. In each year, the costs of salary (or personnel compensation) and benefits for FDA employees account for between 50 and 60 percent of the funds available to, and used by, FDA. Almost all of the remaining funds (operating funds) available to FDA are used to support FDA employees for paying rent, travel, utility, information technology, and other operating costs. A. Estimating the Full Cost per Direct Work Hour in FY 2020 Full-time Equivalent (FTE) reflects the total number of regular straight-time hours—not including overtime or holiday hours—worked by employees, divided by the number of compensable hours applicable to each fiscal year. Annual leave, sick leave, compensatory time off, and other approved leave categories are considered ‘‘hours worked’’ for purposes of defining FTE employment. In general, the starting point for estimating the full cost per direct work hour is to estimate the cost of an FTE or paid staff year. Calculating an Agency-wide total cost per FTE requires three primary cost elements: Payroll, non-payroll, and rent. We have used an average of past year cost elements to predict the FY 2020 cost. The FY 2020 FDA-wide average cost for payroll (salaries and benefits) is $160,885; non-payroll—including equipment, supplies, information technology, general and administrative overhead—is $92,828; and rent, including cost allocation analysis and adjustments for other rent and rentrelated costs, is $24,888 per paid staff year, excluding travel costs. Summing the average cost of an FTE for payroll, non-payroll, and rent, brings the FY 2020 average fully supported cost to $278,602 per FTE, excluding travel costs. FDA will use this base unit E:\FR\FM\23JYN1.SGM 23JYN1 35396 Federal Register / Vol. 84, No. 141 / Tuesday, July 23, 2019 / Notices fee in determining the hourly fee rate for third-party certification user fees for FY 2020 prior to including travel costs as applicable for the activity. To calculate an hourly rate, FDA must divide the FY 2020 average fully supported cost of $278,602 per FTE by the average number of supported direct FDA work hours in FY 2018—the last FY for which data are available. See table 1. TABLE 1—SUPPORTED DIRECT FDA WORK HOURS IN A PAID STAFF YEAR IN FY 2018 Total number of hours in a paid staff year ............................... Less: 10 paid holidays .................... 20 days of annual leave ....... 10 days of sick leave ............ 12.5 days of training ............. 26.5 days of general administration .............................. 26.5 days of travel ................ 2 hours of meetings per week .................................. 2,080 ¥80 ¥160 ¥80 ¥100 ¥184 ¥212 ¥104 Net Supported Direct FDA Work Hours Available for Assignments .................. 1,160 jspears on DSK30JT082PROD with NOTICES Dividing the average fully supported FTE cost in FY 2020 ($278,602) by the total number of supported direct work hours available for assignment in FY 2018 (1,160) results in an average fully supported cost of $240 (rounded to the nearest dollar), excluding travel costs, per supported direct work hour in FY 2020. B. Adjusting FY 2018 Travel Costs for Inflation To Estimate FY 2020 Travel Costs To adjust the hourly rate for FY 2020, FDA must estimate the cost of inflation in each year for FY 2019 and FY 2020. FDA uses the method prescribed for estimating inflationary costs under the Prescription Drug User Fee Act (PDUFA) provisions of the FD&C Act (section 736(c)(1) (21 U.S.C. 379h(c)(1)), the statutory method for inflation adjustment in the FD&C Act that FDA has used consistently. FDA previously determined the FY 2019 inflation rate to be 1.7708 percent; this rate was published in the FY 2019 PDUFA user fee rates notice in the Federal Register 83 FR 37504, August 1, 2018). Utilizing the method set forth in section 736(c)(1) of the FD&C Act, FDA has calculated an inflation rate of 1.7708 percent for FY 2019 and 2.3964 percent for FY 2020, and FDA intends to use this inflation rate to make inflation adjustments for FY 2020 for several of its user fee programs; the derivation of this rate will VerDate Sep<11>2014 16:43 Jul 22, 2019 Jkt 247001 be published in the Federal Register in the FY 2020 notice for the PDUFA user fee rates. The compounded inflation rate for FYs 2019 and 2020, therefore, is 1.042096 (or 4.2096 percent) (1 plus 1.7708 percent times 1 plus 2.3964 percent). The average fully supported cost per supported direct FDA work hour, excluding travel costs, of $240 already takes into account inflation as the calculation above is based on FY 2020 predicted costs. FDA will use this base unit fee in determining the hourly fee rate for third-party certification program fees for FY 2020 prior to including travel costs as applicable for the activity. For the purpose of estimating the fee, we are using the travel cost rate for foreign travel because we anticipate that the vast majority of onsite assessments made by FDA under this program will require foreign travel. In FY 2018, the Office of Regulatory Affairs spent a total of $3,229,335 on 455 foreign inspection trips related to FDA’s Center for Food Safety and Applied Nutrition and Center for Veterinary Medicine field activities programs, which averaged a total of $7,097 per foreign inspection trip. These trips averaged 3 weeks (or 120 paid hours) per trip. Dividing $7,097 per trip by 120 hours per trip results in a total and an additional cost of $59 (rounded to the nearest dollar) per paid hour spent for foreign inspection travel costs in FY 2017. To adjust $59 for inflationary increases in FY 2019 and FY 2020, FDA must multiply it by the same inflation factor mentioned previously in this document (1.042096 or 4.2096 percent), which results in an estimated cost of $61 (rounded to the nearest dollar) per paid hour in addition to $240 for a total of $301 per paid hour ($240 plus $61) for each direct hour of work requiring foreign inspection travel. FDA will use these rates in charging fees in FY 2020 when travel is required for the thirdparty certification program. TABLE 2—FSMA FEE SCHEDULE FOR FY 2020 Fee rates for FY 2020 Fee category Hourly rate without travel ......... Hourly rate if travel is required $240 301 III. Fees for Accreditation Bodies and Certification Bodies in the Third-Party Certification Program Under Section 808(c)(8) of the FD&C Act The third-party certification program assesses application fees and annual fees. In FY 2020, the only fees that PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 could be collected by FDA under section 808(c)(8) of the FD&C Act are the initial application fee for accreditation bodies seeking recognition, the annual fee for recognized accreditation bodies, the annual fee for certification bodies accredited by a recognized accreditation body, and the initial application fee for a certification body seeking direct accreditation from FDA. Table 3 provides an overview of the fees for FY 2020. TABLE 3—FSMA THIRD-PARTY CERTIFICATION PROGRAM USER FEE SCHEDULE FOR FY 2020 Fee category Initial Application Fee for Accreditation Body Seeking Recognition ........................... Annual Fee for Recognized Accreditation Body .................... Annual Fee for Accredited Certification Body ........................ Initial Application Fee for a Certification Body Seeking Direct Accreditation from FDA ......... Fee rates for FY 2020 $41,328 1,945 2,432 41,328 A. Application Fee for Accreditation Bodies Applying for Recognition in the Third-Party Certification Program Under Section 808(c)(8) of the FD&C Act Section 1.705(a)(1) (21 CFR 1.705(a)(1)) establishes an application fee for accreditation bodies applying for initial recognition that represents the estimated average cost of the work FDA performs in reviewing and evaluating initial applications for recognition of accreditation bodies. The fee is based on the fully supported FTE hourly rates and estimates of the number of hours it would take FDA to perform relevant activities. These estimates represent FDA’s current thinking, and as the program evolves, FDA will continue to reconsider the estimated hours. Based on data we have acquired since starting the program, we estimate that it would take, on average, 70 person-hours to review an accreditation body’s submitted application, 48 person-hours for an onsite performance evaluation of the applicant (including travel and other steps necessary for a fully supported FTE to complete an onsite assessment), and 42 person-hours to prepare a written report documenting the onsite assessment. FDA employees review applications and prepare reports from their worksites, so we use the fully supported FTE hourly rate excluding travel, $240/ hour, to calculate the portion of the user E:\FR\FM\23JYN1.SGM 23JYN1 Federal Register / Vol. 84, No. 141 / Tuesday, July 23, 2019 / Notices fee attributable to those activities: $240/ hour × (70 hours + 42 hours) = $26,880. FDA employees will likely travel to foreign countries for the onsite performance evaluations because most accreditation bodies are anticipated to be located in foreign countries. For this portion of the fee we use the fully supported FTE hourly rate for work requiring travel, $301/hour, to calculate the portion of the user fee attributable to those activities: $301/hour × 48 hours (i.e., two fully supported FTEs × ((2 travel days × 8 hours) + (1 day onsite × 8 hours))) = $14,448. The estimated average cost of the work FDA performs in total for reviewing an initial application for recognition for an accreditation body based on these figures would be $26,880 + $14,448 = $41,328. Therefore, the application fee for accreditation bodies applying for recognition in FY 2020 will be $41,328. jspears on DSK30JT082PROD with NOTICES B. Annual Fee for Accreditation Bodies Participating in the Third-Party Certification Program Under Section 808(c)(8) of the FD&C Act To calculate the annual fee for each recognized accreditation body, FDA takes the estimated average cost of work FDA performs to monitor performance of a single recognized accreditation body and annualizes that over the average term of recognition. At this time we assume an average term of recognition of 5 years. We also assume that FDA will monitor 10 percent of recognized accreditation bodies onsite. As the program proceeds, we will adjust the term of recognition as appropriate. We estimate that for one performance evaluation of a recognized accreditation body, it would take, on average (taking into account that not all recognized accreditation bodies would be monitored onsite), 33 hours for FDA to conduct records review, 8 hours to prepare a report detailing the records review and onsite performance evaluation, and 6 hours of onsite performance evaluation (i.e., 10 percent × 60 hours). Using the fully supported FTE hourly rates in table 2, the estimated average cost of the work FDA performs to monitor performance of a single recognized accreditation body would be $7,920 ($240/hour × (25 hours + 8 hours)) plus $1,806 ($301/hour × 6 hours), which is $9,726. Annualizing this amount over 5 years would lead to an annual fee for recognized accreditation bodies of $1,945 for FY 2020. VerDate Sep<11>2014 16:43 Jul 22, 2019 Jkt 247001 C. Annual Fee for Certification Bodies Accredited by a Recognized Accreditation Body in the Third-Party Certification Program Under Section 808(c)(8) of the FD&C Act To calculate the annual fee for a certification body accredited by a recognized accreditation body, FDA takes the estimated average cost of work FDA performs to monitor performance of a single certification body accredited by a recognized accreditation body and annualizes that over the average term of accreditation. At this time we assume an average term of accreditation of 4 years. This fee is based on the fully supported FTE hourly rates and estimates of the number of hours it would take FDA to perform relevant activities. We estimate that FDA would conduct, on average, the same activities, for the same amount of time to monitor certification bodies accredited by a recognized accreditation body as we would to monitor an accreditation body recognized by FDA. Using the fully supported FTE hourly rates in table 2, the estimated average cost of the work FDA performs to monitor performance of a single accredited certification body would be $7,920 ($240/hour × (25 hours + 8 hours)) plus $1,806 ($301/hour × 6 hours), which is $9,726. Annualizing this amount over 4 years would lead to an annual fee for accredited certification bodies of $2,432 for FY 2020. D. Initial Application Fee for Certification Bodies Seeking Direct Accreditation From FDA in the ThirdParty Certification Program Under Section 808(c)(8) of the FD&C Act Section 1.705(a)(3) establishes an application fee for certification bodies applying for direct accreditation from FDA that represents the estimated average cost of the work FDA performs in reviewing and evaluating initial applications for direct accreditation of certification bodies. The fee is based on the fully supported FTE hourly rates and estimates of the number of hours it would take FDA to perform relevant activities. These estimates represent FDA’s current thinking, and as the program evolves, FDA will reconsider the estimated hours. We estimate that it would take, on average, 70 person-hours to review a certification body’s submitted application, 48 person-hours for an onsite performance evaluation of the applicant (including travel and other steps necessary for a fully supported FTE to complete an onsite assessment), and 42 person-hours to prepare a written report documenting the onsite assessment. PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 35397 FDA employees are likely to review applications and prepare reports from their worksites, so we use the fully supported FTE hourly rate excluding travel, $240/hour, to calculate the portion of the user fee attributable to those activities: $240/hour × (70 hours + 42 hours) = $26,880. FDA employees will likely travel to foreign countries for the onsite performance evaluations because most certification bodies are anticipated to be located in foreign countries. For this portion of the fee we use the fully supported FTE hourly rate for work requiring travel, $301/hour, to calculate the portion of the user fee attributable to those activities: $301/ hour × 48 hours (i.e., two fully supported FTEs × ((2 travel days × 8 hours) + (1 day onsite × 8 hours))) = $14,448. The estimated average cost of the work FDA performs in total for reviewing an initial application for direct accreditation of a certification body based on these figures would be $26,880 + $14,448 = $41,328. Therefore, the application fee for certification bodies applying for direct accreditation from FDA in FY 2020 will be $41,328. IV. Estimated Fees for Accreditation Bodies and Certification Bodies in Other Fee Categories for FY 2020 Section 1.705(a) also establishes application fees for recognized accreditation bodies submitting renewal applications and certification bodies applying for renewal of direct accreditation. Section 1.705(b) also establishes annual fees for certification bodies directly accredited by FDA. Although we will not be collecting these other fees in FY 2020, for transparency and planning purposes, we have provided an estimate of what these fees would be for FY 2020 based on the fully supported FTE hourly rates for FY 2020 and estimates of the number of hours it would take FDA to perform relevant activities as outlined in the Final Regulatory Impact Analysis for the Third-Party Certification Regulation. Table 4 provides an overview of the estimated fees for other fee categories. TABLE 4—ESTIMATED FEE RATES FOR OTHER FEE CATEGORIES UNDER THE FSMA THIRD-PARTY CERTIFICATION PROGRAM Fee category Renewal application fee for recognized accreditation body ... Renewal application fee for directly accredited certification body ...................................... E:\FR\FM\23JYN1.SGM 23JYN1 Estimated fee rates for FY 2020 $24,622 24,622 35398 Federal Register / Vol. 84, No. 141 / Tuesday, July 23, 2019 / Notices When paying by wire transfer, it is TABLE 4—ESTIMATED FEE RATES FOR OTHER FEE CATEGORIES UNDER required that the invoice number is THE FSMA THIRD-PARTY CERTIFI- included; without the invoice number the payment may not be applied. The CATION PROGRAM—Continued originating financial institution may charge a wire transfer fee. If the financial institution charges a wire Fee category transfer fee, it is required to add that amount to the payment to ensure that the invoice is paid in full. For Annual fee for certification body directly accredited by FDA .... 19,720 international wire transfers, please inquire with the financial institutions prior to submitting the payment. Use the V. How must the fee be paid? following account information when Accreditation bodies seeking initial sending a wire transfer: U.S. Department recognition must submit the application of the Treasury, TREAS NYC, 33 Liberty fee with the application. St., New York, NY 10045, Account For recognized accreditation bodies Name: Food and Drug Administration, and accredited certification bodies, an Account No.: 75060099, Routing No.: invoice will be sent annually. Payment 021030004, Swift No.: FRNYUS33. must be made within 30 days of the To send a check by a courier such as receipt date. The payment must be made Federal Express, the courier must in U.S. currency from a U.S. bank by deliver the check and printed copy of one of the following methods: Wire the cover sheet to: U.S. Bank, Attn: transfer, electronically, check, bank Government Lockbox 979108, 1005 draft, or U.S. postal money order made Convention Plaza, St. Louis, MO 63101. payable to the Food and Drug (Note: This address is for courier Administration. The preferred payment delivery only. If you have any questions method is online using an electronic concerning courier delivery, contact check (Automated Clearing House U.S. Bank at 314–418–4013. This phone (ACH), also known as eCheck) or credit number is only for questions about card (Discover, VISA, MasterCard, courier delivery.) American Express). Secure electronic The tax identification number of FDA payments can be submitted using the is 53–0196965. (Note: In no case should User Fees Payment Portal at https:// the payment for the fee be submitted to userfees.fda.gov/pay or the Pay.gov payment option is available to you after FDA with the invoice.) you submit a cover sheet. (Note: Only VI. What are the consequences of not full payments are accepted. No partial paying this fee? payments can be made online.) Once The consequences of not paying these you have found your invoice, select fees are outlined in 21 CFR 1.725. If ‘‘Pay Now’’ to be redirected to Pay.gov. Electronic payment options are based on FDA does not receive an application fee the balance due. Payment by credit card with an application for recognition, the application will be considered is available only for balances less than incomplete and FDA will not review the $25,000. If the balance exceeds this application. If a recognized amount, only the ACH option is available. Payments must be made using accreditation body fails to submit its U.S. bank accounts as well as U.S. credit annual user fee within 30 days of the due date, we will suspend its cards. When paying by check, bank draft, or recognition. If the recognized U.S. postal money order, please include accreditation body fails to submit its the invoice number. Also write the FDA annual user fee within 90 days of the post office box number (P.O. Box due date, we will revoke its recognition. 979108) on the enclosed check, bank If an accredited certification body fails draft, or money order. Mail the payment to pay its annual fee within 30 days of and a copy of the invoice to: Food and the due date, we will suspend its Drug Administration, P.O. Box 979108, accreditation. If the accredited St. Louis, MO 63197–9000. certification body fails to pay its annual Estimated fee rates for FY 2020 fee within 90 days of the due date, we will withdraw its accreditation. Dated: July 18, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019–15622 Filed 7–22–19; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA–2018–N–3138; FDA– 2009–N–0232; FDA–2018–N–4465; FDA– 2018–N–4206; FDA–2018–N–3758; FDA– 2015–D–1163; FDA–2012–N–0559; FDA– 2015–N–3815; FDA–2018–N–3353; and FDA–2018–N–2973] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A–12M, 11601 Landsdown St., North Bethesda, MD 20852, 301–796–7726, PRAStaff@ fda.hhs.gov. SUMMARY: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/public/do/ PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. SUPPLEMENTARY INFORMATION: jspears on DSK30JT082PROD with NOTICES TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB OMB control No. Title of collection Experimental Study of an Accelerated Approval Disclosure ................................................................................... Interstate Shellfish Dealer’s Certificate ................................................................................................................... Administrative Detention and Banned Medical Devices ......................................................................................... Medical Device User Fee Small Business Qualifications and Certifications .......................................................... VerDate Sep<11>2014 16:43 Jul 22, 2019 Jkt 247001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\23JYN1.SGM 23JYN1 0910–0872 0910–0021 0910–0114 0910–0508 Date approval expires 6/30/2020 5/31/2022 5/31/2022 5/31/2022

Agencies

[Federal Register Volume 84, Number 141 (Tuesday, July 23, 2019)]
[Notices]
[Pages 35395-35398]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15622]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-4119]

Food Safety Modernization Act Third-Party Certification Program
User Fee Rate for Fiscal Year 2020

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
fiscal year (FY) 2020 annual fee rate for recognized accreditation
bodies and accredited certification bodies, and the fee rate for
accreditation bodies applying to be recognized in the third-party
certification program that is authorized by the Federal Food, Drug, and
Cosmetic Act (FD&C Act), as amended by the FDA Food Safety
Modernization Act (FSMA). We are also announcing the fee rate for
certification bodies that are applying to be directly accredited by
FDA.

DATES: This fee is effective October 1, 2019.

FOR FURTHER INFORMATION CONTACT: Donald Prater, Office of Food Policy
and Response, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 1, Rm. 3202, Silver Spring, MD 20993, 301-348-3007.

SUPPLEMENTARY INFORMATION:

I. Background

Section 307 of FSMA (Pub. L. 111-153), Accreditation of Third-Party
Auditors, amended the FD&C Act to create a new provision, section 808,
under the same name. Section 808 of the FD&C Act (21 U.S.C. 384d)
directs FDA to establish a program for accreditation of third-party
certification bodies \1\ conducting food safety audits and issuing food
and facility certifications to eligible foreign entities (including
registered foreign food facilities) that meet our applicable
requirements. Under this provision, we established a system for FDA to
recognize accreditation bodies to accredit certification bodies, except
for limited circumstances in which we may directly accredit
certification bodies to participate in the third-party certification
program.
---------------------------------------------------------------------------

\1\ For the reasons explained in the third-party certification
final rule (80 FR 74570 at 74578 to 74579, November 27, 2015), and
for consistency with the implementing regulations for the third-
party certification program in 21 CFR parts 1, 11, and 16, this
notice uses the term ``third-party certification body'' rather than
the term ``third-party auditor'' used in section 808(a)(3) of the
FD&C Act.
---------------------------------------------------------------------------

Section 808(c)(8) of the FD&C Act directs FDA to establish a
reimbursement (user fee) program by which we assess fees and require
reimbursement for the work FDA performs to establish and administer the
third-party certification program under section 808 of the FD&C Act.
The user fee program for the third-party certification program was
established by a final rule entitled ``Amendments to Accreditation of
Third-Party Certification Bodies To Conduct Food Safety Audits and To
Issue Certifications To Provide for the User Fee Program'' (81 FR
90186, December 14, 2016).
The FSMA FY 2020 third-party certification program user fee rate
announced in this notice is effective on October 1, 2019, and will
remain in effect through September 30, 2020.

II. Estimating the Average Cost of a Supported Direct FDA Work Hour for
FY 2020

FDA must estimate its costs for each activity in order to establish
fee rates for FY 2020. In each year, the costs of salary (or personnel
compensation) and benefits for FDA employees account for between 50 and
60 percent of the funds available to, and used by, FDA. Almost all of
the remaining funds (operating funds) available to FDA are used to
support FDA employees for paying rent, travel, utility, information
technology, and other operating costs.

A. Estimating the Full Cost per Direct Work Hour in FY 2020

Full-time Equivalent (FTE) reflects the total number of regular
straight-time hours--not including overtime or holiday hours--worked by
employees, divided by the number of compensable hours applicable to
each fiscal year. Annual leave, sick leave, compensatory time off, and
other approved leave categories are considered ``hours worked'' for
purposes of defining FTE employment.
In general, the starting point for estimating the full cost per
direct work hour is to estimate the cost of an FTE or paid staff year.
Calculating an Agency-wide total cost per FTE requires three primary
cost elements: Payroll, non-payroll, and rent.
We have used an average of past year cost elements to predict the
FY 2020 cost. The FY 2020 FDA-wide average cost for payroll (salaries
and benefits) is $160,885; non-payroll--including equipment, supplies,
information technology, general and administrative overhead--is
$92,828; and rent, including cost allocation analysis and adjustments
for other rent and rent-related costs, is $24,888 per paid staff year,
excluding travel costs.
Summing the average cost of an FTE for payroll, non-payroll, and
rent, brings the FY 2020 average fully supported cost to $278,602 per
FTE, excluding travel costs. FDA will use this base unit

[[Page 35396]]

fee in determining the hourly fee rate for third-party certification
user fees for FY 2020 prior to including travel costs as applicable for
the activity.
To calculate an hourly rate, FDA must divide the FY 2020 average
fully supported cost of $278,602 per FTE by the average number of
supported direct FDA work hours in FY 2018--the last FY for which data
are available. See table 1.

Table 1--Supported Direct FDA Work Hours in a Paid Staff Year in FY 2018
------------------------------------------------------------------------

------------------------------------------------------------------------
Total number of hours in a paid staff year................. 2,080
Less:
10 paid holidays......................................... -80
20 days of annual leave.................................. -160
10 days of sick leave.................................... -80
12.5 days of training.................................... -100
26.5 days of general administration...................... -184
26.5 days of travel...................................... -212
2 hours of meetings per week............................. -104
------------
Net Supported Direct FDA Work Hours Available for 1,160
Assignments...........................................
------------------------------------------------------------------------

Dividing the average fully supported FTE cost in FY 2020 ($278,602)
by the total number of supported direct work hours available for
assignment in FY 2018 (1,160) results in an average fully supported
cost of $240 (rounded to the nearest dollar), excluding travel costs,
per supported direct work hour in FY 2020.

B. Adjusting FY 2018 Travel Costs for Inflation To Estimate FY 2020
Travel Costs

To adjust the hourly rate for FY 2020, FDA must estimate the cost
of inflation in each year for FY 2019 and FY 2020. FDA uses the method
prescribed for estimating inflationary costs under the Prescription
Drug User Fee Act (PDUFA) provisions of the FD&C Act (section 736(c)(1)
(21 U.S.C. 379h(c)(1)), the statutory method for inflation adjustment
in the FD&C Act that FDA has used consistently. FDA previously
determined the FY 2019 inflation rate to be 1.7708 percent; this rate
was published in the FY 2019 PDUFA user fee rates notice in the Federal
Register 83 FR 37504, August 1, 2018). Utilizing the method set forth
in section 736(c)(1) of the FD&C Act, FDA has calculated an inflation
rate of 1.7708 percent for FY 2019 and 2.3964 percent for FY 2020, and
FDA intends to use this inflation rate to make inflation adjustments
for FY 2020 for several of its user fee programs; the derivation of
this rate will be published in the Federal Register in the FY 2020
notice for the PDUFA user fee rates. The compounded inflation rate for
FYs 2019 and 2020, therefore, is 1.042096 (or 4.2096 percent) (1 plus
1.7708 percent times 1 plus 2.3964 percent).
The average fully supported cost per supported direct FDA work
hour, excluding travel costs, of $240 already takes into account
inflation as the calculation above is based on FY 2020 predicted costs.
FDA will use this base unit fee in determining the hourly fee rate for
third-party certification program fees for FY 2020 prior to including
travel costs as applicable for the activity. For the purpose of
estimating the fee, we are using the travel cost rate for foreign
travel because we anticipate that the vast majority of onsite
assessments made by FDA under this program will require foreign travel.
In FY 2018, the Office of Regulatory Affairs spent a total of
$3,229,335 on 455 foreign inspection trips related to FDA's Center for
Food Safety and Applied Nutrition and Center for Veterinary Medicine
field activities programs, which averaged a total of $7,097 per foreign
inspection trip. These trips averaged 3 weeks (or 120 paid hours) per
trip. Dividing $7,097 per trip by 120 hours per trip results in a total
and an additional cost of $59 (rounded to the nearest dollar) per paid
hour spent for foreign inspection travel costs in FY 2017. To adjust
$59 for inflationary increases in FY 2019 and FY 2020, FDA must
multiply it by the same inflation factor mentioned previously in this
document (1.042096 or 4.2096 percent), which results in an estimated
cost of $61 (rounded to the nearest dollar) per paid hour in addition
to $240 for a total of $301 per paid hour ($240 plus $61) for each
direct hour of work requiring foreign inspection travel. FDA will use
these rates in charging fees in FY 2020 when travel is required for the
third-party certification program.

Table 2--FSMA Fee Schedule for FY 2020
------------------------------------------------------------------------
Fee rates
Fee category for FY 2020
------------------------------------------------------------------------
Hourly rate without travel................................. $240
Hourly rate if travel is required.......................... 301
------------------------------------------------------------------------

III. Fees for Accreditation Bodies and Certification Bodies in the
Third-Party Certification Program Under Section 808(c)(8) of the FD&C
Act

The third-party certification program assesses application fees and
annual fees. In FY 2020, the only fees that could be collected by FDA
under section 808(c)(8) of the FD&C Act are the initial application fee
for accreditation bodies seeking recognition, the annual fee for
recognized accreditation bodies, the annual fee for certification
bodies accredited by a recognized accreditation body, and the initial
application fee for a certification body seeking direct accreditation
from FDA. Table 3 provides an overview of the fees for FY 2020.

Table 3--FSMA Third-Party Certification Program User Fee Schedule for FY
2020
------------------------------------------------------------------------
Fee rates
Fee category for FY 2020
------------------------------------------------------------------------
Initial Application Fee for Accreditation Body Seeking $41,328
Recognition...............................................
Annual Fee for Recognized Accreditation Body............... 1,945
Annual Fee for Accredited Certification Body............... 2,432
Initial Application Fee for a Certification Body Seeking 41,328
Direct Accreditation from FDA.............................
------------------------------------------------------------------------

A. Application Fee for Accreditation Bodies Applying for Recognition in
the Third-Party Certification Program Under Section 808(c)(8) of the
FD&C Act

Section 1.705(a)(1) (21 CFR 1.705(a)(1)) establishes an application
fee for accreditation bodies applying for initial recognition that
represents the estimated average cost of the work FDA performs in
reviewing and evaluating initial applications for recognition of
accreditation bodies.
The fee is based on the fully supported FTE hourly rates and
estimates of the number of hours it would take FDA to perform relevant
activities. These estimates represent FDA's current thinking, and as
the program evolves, FDA will continue to reconsider the estimated
hours. Based on data we have acquired since starting the program, we
estimate that it would take, on average, 70 person-hours to review an
accreditation body's submitted application, 48 person-hours for an
onsite performance evaluation of the applicant (including travel and
other steps necessary for a fully supported FTE to complete an onsite
assessment), and 42 person-hours to prepare a written report
documenting the onsite assessment.
FDA employees review applications and prepare reports from their
worksites, so we use the fully supported FTE hourly rate excluding
travel, $240/hour, to calculate the portion of the user

[[Page 35397]]

fee attributable to those activities: $240/hour x (70 hours + 42 hours)
= $26,880. FDA employees will likely travel to foreign countries for
the onsite performance evaluations because most accreditation bodies
are anticipated to be located in foreign countries. For this portion of
the fee we use the fully supported FTE hourly rate for work requiring
travel, $301/hour, to calculate the portion of the user fee
attributable to those activities: $301/hour x 48 hours (i.e., two fully
supported FTEs x ((2 travel days x 8 hours) + (1 day onsite x 8
hours))) = $14,448. The estimated average cost of the work FDA performs
in total for reviewing an initial application for recognition for an
accreditation body based on these figures would be $26,880 + $14,448 =
$41,328. Therefore, the application fee for accreditation bodies
applying for recognition in FY 2020 will be $41,328.

B. Annual Fee for Accreditation Bodies Participating in the Third-Party
Certification Program Under Section 808(c)(8) of the FD&C Act

To calculate the annual fee for each recognized accreditation body,
FDA takes the estimated average cost of work FDA performs to monitor
performance of a single recognized accreditation body and annualizes
that over the average term of recognition. At this time we assume an
average term of recognition of 5 years. We also assume that FDA will
monitor 10 percent of recognized accreditation bodies onsite. As the
program proceeds, we will adjust the term of recognition as
appropriate. We estimate that for one performance evaluation of a
recognized accreditation body, it would take, on average (taking into
account that not all recognized accreditation bodies would be monitored
onsite), 33 hours for FDA to conduct records review, 8 hours to prepare
a report detailing the records review and onsite performance
evaluation, and 6 hours of onsite performance evaluation (i.e., 10
percent x 60 hours). Using the fully supported FTE hourly rates in
table 2, the estimated average cost of the work FDA performs to monitor
performance of a single recognized accreditation body would be $7,920
($240/hour x (25 hours + 8 hours)) plus $1,806 ($301/hour x 6 hours),
which is $9,726. Annualizing this amount over 5 years would lead to an
annual fee for recognized accreditation bodies of $1,945 for FY 2020.

C. Annual Fee for Certification Bodies Accredited by a Recognized
Accreditation Body in the Third-Party Certification Program Under
Section 808(c)(8) of the FD&C Act

To calculate the annual fee for a certification body accredited by
a recognized accreditation body, FDA takes the estimated average cost
of work FDA performs to monitor performance of a single certification
body accredited by a recognized accreditation body and annualizes that
over the average term of accreditation. At this time we assume an
average term of accreditation of 4 years. This fee is based on the
fully supported FTE hourly rates and estimates of the number of hours
it would take FDA to perform relevant activities. We estimate that FDA
would conduct, on average, the same activities, for the same amount of
time to monitor certification bodies accredited by a recognized
accreditation body as we would to monitor an accreditation body
recognized by FDA. Using the fully supported FTE hourly rates in table
2, the estimated average cost of the work FDA performs to monitor
performance of a single accredited certification body would be $7,920
($240/hour x (25 hours + 8 hours)) plus $1,806 ($301/hour x 6 hours),
which is $9,726. Annualizing this amount over 4 years would lead to an
annual fee for accredited certification bodies of $2,432 for FY 2020.

D. Initial Application Fee for Certification Bodies Seeking Direct
Accreditation From FDA in the Third-Party Certification Program Under
Section 808(c)(8) of the FD&C Act

Section 1.705(a)(3) establishes an application fee for
certification bodies applying for direct accreditation from FDA that
represents the estimated average cost of the work FDA performs in
reviewing and evaluating initial applications for direct accreditation
of certification bodies.
The fee is based on the fully supported FTE hourly rates and
estimates of the number of hours it would take FDA to perform relevant
activities. These estimates represent FDA's current thinking, and as
the program evolves, FDA will reconsider the estimated hours. We
estimate that it would take, on average, 70 person-hours to review a
certification body's submitted application, 48 person-hours for an
onsite performance evaluation of the applicant (including travel and
other steps necessary for a fully supported FTE to complete an onsite
assessment), and 42 person-hours to prepare a written report
documenting the onsite assessment.
FDA employees are likely to review applications and prepare reports
from their worksites, so we use the fully supported FTE hourly rate
excluding travel, $240/hour, to calculate the portion of the user fee
attributable to those activities: $240/hour x (70 hours + 42 hours) =
$26,880. FDA employees will likely travel to foreign countries for the
onsite performance evaluations because most certification bodies are
anticipated to be located in foreign countries. For this portion of the
fee we use the fully supported FTE hourly rate for work requiring
travel, $301/hour, to calculate the portion of the user fee
attributable to those activities: $301/hour x 48 hours (i.e., two fully
supported FTEs x ((2 travel days x 8 hours) + (1 day onsite x 8
hours))) = $14,448. The estimated average cost of the work FDA performs
in total for reviewing an initial application for direct accreditation
of a certification body based on these figures would be $26,880 +
$14,448 = $41,328. Therefore, the application fee for certification
bodies applying for direct accreditation from FDA in FY 2020 will be
$41,328.

IV. Estimated Fees for Accreditation Bodies and Certification Bodies in
Other Fee Categories for FY 2020

Section 1.705(a) also establishes application fees for recognized
accreditation bodies submitting renewal applications and certification
bodies applying for renewal of direct accreditation. Section 1.705(b)
also establishes annual fees for certification bodies directly
accredited by FDA.
Although we will not be collecting these other fees in FY 2020, for
transparency and planning purposes, we have provided an estimate of
what these fees would be for FY 2020 based on the fully supported FTE
hourly rates for FY 2020 and estimates of the number of hours it would
take FDA to perform relevant activities as outlined in the Final
Regulatory Impact Analysis for the Third-Party Certification
Regulation. Table 4 provides an overview of the estimated fees for
other fee categories.

Table 4--Estimated Fee Rates for Other Fee Categories Under the FSMA
Third-Party Certification Program
------------------------------------------------------------------------
Estimated
Fee category fee rates
for FY 2020
------------------------------------------------------------------------
Renewal application fee for recognized accreditation body.. $24,622
Renewal application fee for directly accredited 24,622
certification body........................................

[[Page 35398]]

Annual fee for certification body directly accredited by 19,720
FDA.......................................................
------------------------------------------------------------------------

V. How must the fee be paid?

Accreditation bodies seeking initial recognition must submit the
application fee with the application.
For recognized accreditation bodies and accredited certification
bodies, an invoice will be sent annually. Payment must be made within
30 days of the receipt date. The payment must be made in U.S. currency
from a U.S. bank by one of the following methods: Wire transfer,
electronically, check, bank draft, or U.S. postal money order made
payable to the Food and Drug Administration. The preferred payment
method is online using an electronic check (Automated Clearing House
(ACH), also known as eCheck) or credit card (Discover, VISA,
MasterCard, American Express). Secure electronic payments can be
submitted using the User Fees Payment Portal at https://userfees.fda.gov/pay or the Pay.gov payment option is available to you
after you submit a cover sheet. (Note: Only full payments are accepted.
No partial payments can be made online.) Once you have found your
invoice, select ``Pay Now'' to be redirected to Pay.gov. Electronic
payment options are based on the balance due. Payment by credit card is
available only for balances less than $25,000. If the balance exceeds
this amount, only the ACH option is available. Payments must be made
using U.S. bank accounts as well as U.S. credit cards.
When paying by check, bank draft, or U.S. postal money order,
please include the invoice number. Also write the FDA post office box
number (P.O. Box 979108) on the enclosed check, bank draft, or money
order. Mail the payment and a copy of the invoice to: Food and Drug
Administration, P.O. Box 979108, St. Louis, MO 63197-9000.
When paying by wire transfer, it is required that the invoice
number is included; without the invoice number the payment may not be
applied. The originating financial institution may charge a wire
transfer fee. If the financial institution charges a wire transfer fee,
it is required to add that amount to the payment to ensure that the
invoice is paid in full. For international wire transfers, please
inquire with the financial institutions prior to submitting the
payment. Use the following account information when sending a wire
transfer: U.S. Department of the Treasury, TREAS NYC, 33 Liberty St.,
New York, NY 10045, Account Name: Food and Drug Administration, Account
No.: 75060099, Routing No.: 021030004, Swift No.: FRNYUS33.
To send a check by a courier such as Federal Express, the courier
must deliver the check and printed copy of the cover sheet to: U.S.
Bank, Attn: Government Lockbox 979108, 1005 Convention Plaza, St.
Louis, MO 63101. (Note: This address is for courier delivery only. If
you have any questions concerning courier delivery, contact U.S. Bank
at 314-418-4013. This phone number is only for questions about courier
delivery.)
The tax identification number of FDA is 53-0196965. (Note: In no
case should the payment for the fee be submitted to FDA with the
invoice.)

VI. What are the consequences of not paying this fee?

The consequences of not paying these fees are outlined in 21 CFR
1.725. If FDA does not receive an application fee with an application
for recognition, the application will be considered incomplete and FDA
will not review the application. If a recognized accreditation body
fails to submit its annual user fee within 30 days of the due date, we
will suspend its recognition. If the recognized accreditation body
fails to submit its annual user fee within 90 days of the due date, we
will revoke its recognition. If an accredited certification body fails
to pay its annual fee within 30 days of the due date, we will suspend
its accreditation. If the accredited certification body fails to pay
its annual fee within 90 days of the due date, we will withdraw its
accreditation.

Dated: July 18, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-15622 Filed 7-22-19; 8:45 am]
BILLING CODE 4164-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.